Roth Capital raised the firm’s price target on Cadre (CDRE) to $44 from $35 and keeps a Buy rating on the shares following the investor day. The firm believes investors “will welcome” the details Cadre provided on its nuclear safety platform, as the business has been viewed as a bit of a “black box” by generalists since the segment was introduced. Roth believes the company’s core business continues to perform well.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDRE: